Clinical trials
Active, not recruiting Phase 2 Thalassemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2019 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Agios Pharmaceuticals, Inc. | 1 |
| Emory University | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thalassemia | 4 |
| Anemia, Sickle Cell | 2 |
| Graft vs Host Disease | 2 |
| Anemia, Aplastic | 1 |
| Fanconi Anemia | 1 |
| Hemoglobinopathies | 1 |
| beta-Thalassemia | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.